Effect of genetic disruption of poly (ADP-ribose) synthetase on delayed production of inflammatory mediators and delayed necrosis during myocardial ischemia-reperfusion injury

Shock

Volumn 13, Issue 1, 2000, Pages 60-66

  Yang, Zequan ^a   Zingarelli, Basilia ^a   Szabó, Csaba ^a,b  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b INOTEK CORPORATION   (United States)

Author keywords

Cytokines; Heart; Ischemia; Nitric oxide; Peroxynitrite; Reperfusion

Indexed keywords

CREATINE PHOSPHATE; INTERLEUKIN 10; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PEROXIDASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ARTICLE; BIOSYNTHESIS; BLOOD; BLOOD PRESSURE; GENETICS; HEART INFARCTION; HEART MUSCLE; HEART RATE; HEMODYNAMICS; IMMUNOLOGY; METABOLISM; MOUSE; MOUSE MUTANT; NECROSIS; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; REPERFUSION INJURY;

ANIMALS; BLOOD PRESSURE; HEART RATE; HEMODYNAMIC PROCESSES; INTERLEUKIN-10; MICE; MICE, KNOCKOUT; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; NECROSIS; PEROXIDASE; PHOSPHOCREATINE; POLY(ADP-RIBOSE) POLYMERASES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033627868     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/00024382-200013010-00011     Document Type: Article

References (40)

1. Le Rhun YL, Kirkland JB, Shah GM: Cellular responses to DNA damage in the absence of poly (ADP-ribose) polymerase. Biochem Biophys Res Commun 245:1-10. 1998.
2. Szabó C, Dawson VL: Role of poly (ADP-ribose) synthetase activation in inflammation and reperfusion injury. Trends Pharmacol Sci 19:287-298. 1998.
3. Gilad E, Zingarelli B, Salzman AL, Szabó C: Protection by inhibition of poly (ADP-ribose) synthetase against oxidant injury in cardiac myoblasts in vitro. J Mol Cell Cardiol 29:2585-2597. 1997.
4. Grupp IL, Jackson TM, Hake P, Grupp G, Szabó C: Protection against hypoxia-reoxygenation in the absence of poly (ADP-ribose) synthetase in isolated working hearts. J Mol Cell Cardiol 31:297-303. 1999.
5. Zingarelli B, Cuzzocrea S, Zsengeller Z, Salzman AL, Szabó C: Inhibition of poly (ADP ribose) synthetase protects against myocardial ischemia and reperfusion injury. Cardiovasc Res 36:205-212, 1997.
6. Zingarelli B, Salzman AL, Szabó C: Genetic disruption of poly (ADP ribose) synthetase inhibits the expression of P-selectin and intercellular adhesion molecule-1 in myocardial ischemia-reperfusion injury. Circ Res 83:85-94, 1998.
7. Thiemermann C, Bowes J, Myint FP, Vane JR: Inhibition of the activity of poly (ADP ribose) synthase reduces ischemia-reperfusion injury in the heart and skeletal muscle. Proc Natl Acad Sci USA 94:679-683, 1997.
8. Walles T, Wang P, Pieper A, Snyder SS, Zweier J: Mice lacking poly (ADP-ribose) polymerase gene show attenuated cellular energy depletion and improved recovery of myocardial function following global ischemia. Circulation 98(Suppl.):I-260, 1998.
9. Bowes J, Piper J, Thiemermann C: Inhibitors of the activity of poly (ADP-ribose) synthetase reduce the cell death caused by hydrogen peroxide in human cardiac myoblasts. Br J Pharmacol 124:1760-1766, 1998.
10. Bowes J, Ruetten H, Martorana PA, Stockhausen H, Thiemermann C: Reduction of myocardial reperfusion injury by an inhibitor of poly (ADP-ribose) synthetase in the pig. Eur J Pharmacol 359:143-150, 1998.
11. Lucchesi BR: Modulation of leukocyte-mediated myocardial reperfusion injury. Ann Rev Physiol 52:561-576, 1990.
12. Dreyer WJ, Michael LH, West MS, Smith CW, Rothlein R, Rossen RD, Anderson DC, Entman ML: Neutrophil accumulation in ischemic canine myocardium: insights into time course, distribution, and mechanism of localization during early reperfusion. Circulation 84:400-411, 1991.
13. Ferrari R: Importance of oxygen free radicals during ischemia and reperfusion in the experimental and clinical setting: oxygen free radicals and the heart. Am J Cardiovasc Pathol 4:103-14, 1992.
14. Bauer PI, Kirsten E, Young LJT, Varadi G, Csonka E, Buki KG, Mikala G, Hu R, Comstock JA, Mendeleyev J, Hakam A, Kun E: Modification of growth related enzymatic pathways and apparent loss of tumorigenicity of a ras-transformed bovine endothelial cell line by treatment with 5-iodo-6-amino-1,2-benzopyrone. Int J Oncol 8:239-252, 1996.
15. Meisterernst M, Stelzer G, Roeder RG: Poly (ADP-ribose) polymerase enhances activator-dependent transcription in vitro. Proc Natl Acad Sci USA 94:2261-2265, 1997.
16. Simbulan-Rosenthal CM, Rosenthal DS, Boulares AH, Hickey RJ, Malkas LH, Coll JM, Smulson ME: Regulation of the expression or recruitment of components of the DNA synthesome by poly (ADP-ribose) polymerase. Biochemistry 37:9363-9370, 1998.
17. Butler AJ, Ordahl CP: Poly (ADP-ribose) polymerase binds with transcription enhancer factor 1 to MCAT1 elements to regulate muscle-specific transcription. Mol Cell Biol 19:296-306, 1999.
18. Wang ZQ, Auer B, Stingl L, Berghammer H, Haidacher D, Schweiger M, Wagner EF: Mice lacking ADPRT and poly(ADP-ribosyl)ation develop normally but are susceptible to skin disease. Genes Dev 9: 510-520, 1995.
19. Guo Y, Wu W, Qiu Y, Tang X, Yang Z, Bolli R: Demonstration of an early and a late phase of ischemic preconditioning in mice. Am J Physiol 275:H1375-H1387, 1998.
20. Takano H, Manchikalapudi S, Tang XL, Qiu Y, Rizvi A, Jadoon AK, Zhang Q, Bolli, R: Nitric oxide synthase is the mediator of late preconditioning against myocardial infarction in conscious rabbits. Circulation 98:441-449, 1998.
21. Yang Z, Zingarelli B, Szabó C: The crucial role of endogenous interleukin-10 production in myocardial ischemia-reperfusion injury. Circulation, in press, 1999.
22. Haskó G, Szabó C, Németh ZH, Salzman AL, Vizi ES: Suppression of IL-12 production by phosphodiesterase inhibition in murine endotoxemia is IL-10 independent. Eur J Immunol 28:468-472, 1998.
23. Szabó C, Virág L, Cuzzocrea S, Scott GJ, Hake P, O'Connor MP, Zingarelli B, Salzman AL, Kun E: Protection against peroxynitrite-induced fibroblast injury and arthritis development by inhibition of poly (ADP-ribose) synthetase. Proc Natl Acad Sci USA 95:3867-3872, 1998.
24. Szabó C, Cuzzocrea S, Zingarelli B, O'Connor M, Salzman AL: Endothelial dysfunction in endotoxic shock: importance of the activation of poly (ADP ribose) synthetase (PARS) by peroxynitrite. J Clin Invest 100: 723-735, 1997.
25. Szabó C, Lim LH, Cuzzocrea S, Getting SJ, Zingarelli B, Flower RJ, Salzman AL, Perretti M: Inhibition of poly (ADP-ribose) synthetase exerts anti-inflammatory effects and inhibits neutrophil recruitment. J Exp Med 186:1041-1049, 1997.
26. Kajstura J, Cheng W, Reiss K, Clark WA, Sonnenblick EH, Krajewski S, Reed JC, Olivetti G, Anversa P: Apoptotic and necrotic myocyte cell deaths are independent contributing variables of infarct size in rats. Lab Invest 74:86-107, 1996.
27. Buja LM, Entman ML: Modes of myocardial cell injury and cell death in ischemic heart disease. Circulation 98:1355-1357, 1998.
28. Sabbah HN, Sharov VG: Apoptosis in heart failure. Prog Cardiovasc Dis 40:549-562, 1998.
29. Yaoita H, Ogawa K, Maehara K, Maruyama Y: Attenuation of ischemia/ reperfusion injury in rats by a caspase inhibitor. Circulation 97:276-281, 1998.
30. Virág L, Scott GS, Marmer D, Salzman AL, Szabó C: Peroxynitrite-induced thymocyte apoptosis: the role of caspases and poly-(ADP-ribose) synthetase (PARS) activation. Immunology 94:345-355, 1998.
31. Virág L, Salzman AL, Szabó C: Poly (ADP-ribose) synthetase activation mediates mitochondrial injury during oxidant-induced cell death. J Immunol 161:3753-3759, 1998.
32. Bromme HJ, Holtz J: Apoptosis in the heart: when and why? Mol Cell Biochem 163-164:261-275, 1996.
33. Hawkins HK, Entman ML, Zhu JY, Youker KA, Berens K, Doré M, Smith CW: Acute inflammatory reaction after myocardial ischemic injury and reperfusion. Am J Pathol 148:1957-1969, 1996.
34. Gurevitch J, Frolkis I, Yuhas Y, Lifschitz-Mercer B, Berger E, Paz Y, Matsa M, Kramer A, Mohr R: Anti-tumor necrosis factor-alpha improves myocardial recovery after ischemia and reperfusion. Am Coll Cardiol 30:1554-1561, 1997.
35. Sugita T, Watarida S, Katsuyama K, Nakajima Y, Yamamoto R, Mori A: Interleukin-10 concentration in children undergoing cardiopulmonary bypass. J Thorac Cardiovasc Surg 112:1127-1128, 1996.
36. Shibata M, Endo S, Inada K, Kuriki S, Harada M, Takino T, Sato N, Arakawa N, Suzuki T, Aoki H, Suzuki T, Hiramori K: Elevated plasma levels of interleukin-1 receptor antagonist and interleukin-10 in patients with acute myocardial infarction. J Interferon Cytokine Res 17:145-150, 1997.
37. Benyó Z, Kiss G, Szabó C, Csáki C, Kovách AGB: Importance of basal nitric oxide synthesis in the regulation of myocardial blood flow. Cardiovasc Res 25:700-703, 1991.
38. Lefer AM, Lefer DJ: The role of nitric oxide and cell adhesion molecules on the microcirculation in ischaemia-reperfusion. Cardiovasc Res 32:743-751, 1996.
39. Akiyama K, Suzuki H, Grant P, Bing RJ: Oxidation products of nitric oxide, NO2 and NO3, in plasma after experimental myocardial infarction. J Mol Cell Cardiol 29:1-9, 1997.
40. Akiyama K, Kimura A, Suzuki H, Takeyama Y, Gluckman TL, Terhakopian A, Katagiri T, Suh KY, Roseto J, Bing RJ: Production of oxidative products of nitric oxide in infarcted human heart. J Am Coll. Cardiol 32:373-379, 1998.